oncology
Research

FMT emerging as a booster shot to immunotherapy-resistant cancer

Immunotherapy may have revolutionised the treatment of many cancers including melanoma, but it might be the gut microbiota that helps further advance those gains. Two phase 1 trials published earlier this year suggest that restoring the gut microbiome via faecal microbiota transplantation (FMT) can help restore sensitivity to anti–PD-1 immunotherapy in patients whose metastatic melanoma ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic